NVO vs. UHS

Last updated Jun 9, 2026

NVO (Novo Nordisk A/S) and UHS (Universal Health Services, Inc.) are both stocks. Both are in the Healthcare sector — NVO in Drug Manufacturers - General, UHS in Medical Care Facilities. Over the past 10 years, NVO returned 6.20%/yr vs 0.99%/yr for UHS. At a 0.16 correlation, their price movements are largely independent.

Performance

NVO vs. UHS - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Novo Nordisk A/S (NVO) and Universal Health Services, Inc. (UHS). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, NVO achieves a -16.56% return, which is significantly higher than UHS's -34.32% return. Over the past 10 years, NVO has outperformed UHS with an annualized return of 6.20%, while UHS has yielded a comparatively lower 0.99% annualized return.

NVO

• 1D: -4.52%
• 1M: -10.96%
• YTD: -16.56%
• 6M: -9.23%
• 1Y: -42.47%
• 3Y*: -17.53%
• 5Y*: 1.78%
• 10Y*: 6.20%

UHS

• 1D: -1.45%
• 1M: -15.82%
• YTD: -34.32%
• 6M: -36.67%
• 1Y: -24.24%
• 3Y*: 2.02%
• 5Y*: -1.67%
• 10Y*: 0.99%

*Multi-year figures are annualized to reflect compound growth (CAGR)

NVO vs. UHS - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
NVO Novo Nordisk A/S	-16.56%	-39.22%	-15.93%	54.84%	22.66%	63.52%	23.33%	28.70%	-12.98%	52.92%
UHS Universal Health Services, Inc.	-34.32%	22.02%	18.19%	8.83%	9.37%	-5.16%	-4.00%	23.62%	3.16%	6.93%

Correlation

The correlation between NVO and UHS is -0.02, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	-0.02
Correlation (3Y) Calculated over the trailing 3-year period	0.12
Correlation (5Y) Calculated over the trailing 5-year period	0.16
Correlation (10Y) Calculated over the trailing 10-year period	0.18
Correlation (All Time) Calculated using the full available price history since Mar 27, 1990	0.16

The correlation between NVO and UHS shifts across timeframes, from -0.02 (1 year) to 0.18 (10 years), reflecting how their relationship changes across market environments.

Fundamentals

EPS NVO : $27.42 UHS : $31.29
PE Ratio NVO : 1.50 UHS : 4.57
PEG Ratio NVO : 0.06 UHS : 0.20
PS Ratio NVO : 0.56 UHS : 0.39
Total Revenue (TTM) NVO : $327.80B UHS : $17.76B
Gross Profit (TTM) NVO : $268.30B UHS : $12.01B
EBITDA (TTM) NVO : $181.54B UHS : $2.79B

Return for Risk

NVO vs. UHS — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

NVO

NVO Risk / Return Rank: 12
NVO Sharpe Ratio Rank: 9
NVO Sortino Ratio Rank: 12
NVO Omega Ratio Rank: 10
NVO Calmar Ratio Rank: 13
NVO Martin Ratio Rank: 17

UHS

UHS Risk / Return Rank: 13
UHS Sharpe Ratio Rank: 10
UHS Sortino Ratio Rank: 13
UHS Omega Ratio Rank: 12
UHS Calmar Ratio Rank: 21
UHS Martin Ratio Rank: 7

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

NVO vs. UHS - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Novo Nordisk A/S (NVO) and Universal Health Services, Inc. (UHS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	NVO	UHS	Difference
Sharpe ratio: Return per unit of total volatility	-0.82	-0.76	-0.06
Sortino ratio: Return per unit of downside risk	-1.01	-0.91	-0.10
Omega ratio: Gain probability vs. loss probability	0.86	0.88	-0.02
Calmar ratio: Return relative to maximum drawdown	-0.77	-0.59	-0.19
Martin ratio: Return relative to average drawdown	-1.14	-1.46	+0.32
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

NVO vs. UHS - Sharpe Ratio Comparison

The current NVO Sharpe Ratio is -0.82, which is comparable to the UHS Sharpe Ratio of -0.76. The chart below compares the historical Sharpe Ratios of NVO and UHS, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	NVO	UHS	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	-0.82	-0.76	-0.06
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	0.05	-0.05	+0.10
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	0.19	0.03	+0.16
Sharpe Ratio (All Time) Calculated using the full available price history	0.47	0.44	+0.03

Drawdowns

NVO vs. UHS - Drawdown Comparison

The maximum NVO drawdown since its inception was -74.70%, which is greater than UHS's maximum drawdown of -60.27%. Use the drawdown chart below to compare losses from any high point for NVO and UHS.

Drawdown Indicators

	NVO	UHS	Difference
Max Drawdown Largest peak-to-trough decline	-74.70%	-60.27%	-14.43%
Max Drawdown (1Y) Largest decline over 1 year	-55.03%	-41.52%	-13.51%
Max Drawdown (3Y) Largest decline over 3 years	-74.70%	-41.52%	-33.18%
Max Drawdown (5Y) Largest decline over 5 years	-74.70%	-44.90%	-29.80%
Max Drawdown (10Y) Largest decline over 10 years	-74.70%	-56.30%	-18.40%
Current Drawdown Current decline from peak	-70.19%	-41.30%	-28.89%
Average Drawdown Average peak-to-trough decline	-17.77%	-14.80%	-2.97%
Ulcer Index Depth and duration of drawdowns from previous peaks	37.21%	16.71%	+20.50%

Volatility

NVO vs. UHS - Volatility Comparison

Novo Nordisk A/S (NVO) has a higher volatility of 9.75% compared to Universal Health Services, Inc. (UHS) at 6.50%. This indicates that NVO's price experiences larger fluctuations and is considered to be riskier than UHS based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	NVO	UHS	Difference
Volatility (1M) Calculated over the trailing 1-month period	9.75%	6.50%	+3.25%
Volatility (6M) Calculated over the trailing 6-month period	38.30%	25.04%	+13.26%
Volatility (1Y) Calculated over the trailing 1-year period	52.08%	32.08%	+20.00%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	38.31%	31.80%	+6.51%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	32.56%	34.38%	-1.82%

Dividends

NVO vs. UHS - Dividend Comparison

NVO's dividend yield for the trailing twelve months is around 4.39%, more than UHS's 0.56% yield.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
NVO Novo Nordisk A/S	4.39%	3.31%	1.68%	1.00%	1.20%	1.35%	1.87%	2.14%	1.45%	1.52%	2.87%	0.92%
UHS Universal Health Services, Inc.	0.56%	0.37%	0.45%	0.52%	0.57%	0.62%	0.15%	0.42%	0.34%	0.35%	0.38%	0.33%

Financials

NVO vs. UHS - Profitability Comparison

The chart below illustrates the profitability comparison between Novo Nordisk A/S and Universal Health Services, Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

NVO - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Novo Nordisk A/S reported a gross profit of 83.23B and revenue of 96.82B. Therefore, the gross margin over that period was 86.0%.

UHS - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Universal Health Services, Inc. reported a gross profit of 0.00 and revenue of 4.50B. Therefore, the gross margin over that period was 0.0%.

NVO - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Novo Nordisk A/S reported an operating income of 59.62B and revenue of 96.82B, resulting in an operating margin of 61.6%.

UHS - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Universal Health Services, Inc. reported an operating income of 502.86M and revenue of 4.50B, resulting in an operating margin of 11.2%.

NVO - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Novo Nordisk A/S reported a net income of 48.56B and revenue of 96.82B, resulting in a net margin of 50.2%.

UHS - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Universal Health Services, Inc. reported a net income of 348.68M and revenue of 4.50B, resulting in a net margin of 7.8%.

Frequently Asked Questions

Can I hold both NVO and UHS in my portfolio?

NVO and UHS have a correlation of -0.02, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, NVO or UHS?

NVO has higher volatility (9.75%) compared to UHS (6.50%). In terms of maximum drawdown, NVO dropped -74.70% vs UHS's -60.27%.

Which has better risk-adjusted returns?

UHS currently has the higher Sharpe Ratio (-0.76 vs -0.82), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.